Cotera A, Lorca E, Saffie A, Sepulveda M
Unidad de Nefrología Intensiva, Hospital J J Aguirre, Universidad de Chile, Santiago.
Rev Med Chil. 1994 Apr;122(4):394-400.
The aim of this work was to evaluate the use of 1 m2 Cuprophan hollow fiber filters for continuous arteriovenous hemodialysis procedures. Thirty one critically ill patients (18 male) aged between 20 and 80 years old, subjected to 35 hemodialysis procedures were studied. Sixteen patients had acute renal failure (10 of these had multiorgan failures) and 15 terminal chronic renal failure. Femoral vessels were used for vascular access and isotonic peritoneal dialysis solution flowing at 16.6 ml/seg as dialyzing solution. No extracorporeal pump assistance was used. Mean procedure time was 76 +/- 69.7 h, filter consumption was 2.8 +/- 2.1 filters/procedure, ultrafiltration rate was 168 ml/min and urea clearance was 19.9 +/- 4.4 ml/min. No replacement solutions were required and good electrolyte and circulating volume control was achieved with excellent hemodynamic stability. Blood urea fell from 116.9 +/- 49.1 to 64 +/- 27.2 mg/dl after the procedure (p < 0.001). Hyperglycemia was observed in eight procedures, six patients developed non infectious vascular access complications and two patients catheter related sepsis. We conclude that continuous arteriovenous hemodialysis using cuprophan membranes is a good renal substitution technique for critically ill patients.
这项工作的目的是评估使用1平方米的铜仿中空纤维滤器进行连续性动静脉血液透析操作的效果。对31例年龄在20至80岁之间、接受了35次血液透析操作的危重症患者(18例男性)进行了研究。16例患者患有急性肾衰竭(其中10例有多器官功能衰竭),15例为终末期慢性肾衰竭。采用股血管作为血管通路,使用等渗腹膜透析液以16.6毫升/秒的流速作为透析液。未使用体外泵辅助。平均操作时间为76±69.7小时,滤器消耗量为2.8±2.1个滤器/次操作,超滤率为168毫升/分钟,尿素清除率为19.9±4.4毫升/分钟。无需补充置换液,通过出色的血流动力学稳定性实现了良好的电解质和循环容量控制。操作后血尿素从116.9±49.1降至64±27.2毫克/分升(p<0.001)。在8次操作中观察到高血糖,6例患者出现非感染性血管通路并发症,2例患者发生导管相关败血症。我们得出结论,使用铜仿膜进行连续性动静脉血液透析是危重症患者良好的肾脏替代技术。